Literature DB >> 16028081

[Direct neuronal effects of statins].

J Bösel1, M Endres.   

Abstract

Statins, i.e. HMG-CoA reductase inhibitors, reduce the risk of stroke and may have therapeutic potential for other neurologic diseases, including multiple sclerosis and Alzheimer's disease. In addition to lowering cholesterol levels, statins exert a number of cholesterol-independent (pleiotropic) effects. While endothelial, anti-thrombotic, anti-inflammatory, and immunomodulatory, i.e. peripheral, effects of statins are well known, little is known about the direct effects on neurons. This may be of clinical relevance because some statins are able to cross the blood-brain barrier. Recent experimental studies demonstrate that statins reduce the activity of neuronal glutamate receptors and protect neurons from excitotoxic insults. At higher doses, however, statins may also inhibit neurite sprouting and even induce neuronal apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16028081     DOI: 10.1007/s00115-005-1963-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  24 in total

Review 1.  Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors.

Authors:  B A Hamelin; J Turgeon
Journal:  Trends Pharmacol Sci       Date:  1998-01       Impact factor: 14.819

2.  Pravastatin and lovastatin in cerebrospinal fluid.

Authors:  J Triscari; J S Markowitz; M W McGovern
Journal:  Clin Neuropharmacol       Date:  1993-12       Impact factor: 1.592

3.  Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site.

Authors:  G Weitz-Schmidt; K Welzenbach; V Brinkmann; T Kamata; J Kallen; C Bruns; S Cottens; Y Takada; U Hommel
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

4.  Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.

Authors:  T Tanaka; I Tatsuno; D Uchida; I Moroo; H Morio; S Nakamura; Y Noguchi; T Yasuda; M Kitagawa; Y Saito; A Hirai
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

5.  Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition.

Authors:  N García-Román; A M Alvarez; M J Toro; A Montes; M J Lorenzo
Journal:  Mol Cell Neurosci       Date:  2001-02       Impact factor: 4.314

6.  3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity.

Authors:  Anna Zacco; James Togo; Katherine Spence; Amanda Ellis; Darlene Lloyd; Steve Furlong; Timothy Piser
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

7.  In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.

Authors:  A Saheki; T Terasaki; I Tamai; A Tsuji
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

8.  Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia.

Authors:  J B Kostis; R C Rosen; A C Wilson
Journal:  J Clin Pharmacol       Date:  1994-10       Impact factor: 3.126

9.  Comparison of fluvastatin and lovastatin blood-brain barrier transfer using in vitro and in vivo methods.

Authors:  F Guillot; P Misslin; M Lemaire
Journal:  J Cardiovasc Pharmacol       Date:  1993-02       Impact factor: 3.105

10.  HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis.

Authors:  Joachim G Schulz; Julian Bösel; Magali Stoeckel; Dirk Megow; Ulrich Dirnagl; Matthias Endres
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.